John L. Kulp III

Director, Business Development at Evrys Bio

John is the Founder and CEO of Conifer Point. He is also Associate Professor and Director of Academic Affairs at the Baruch S. Blumberg Institute of Hepatitic B Research. Dr. Kulp’s background is in the field of bioorganic chemistry with specialization in (i) protein nuclear magnetic resonance (NMR) structure determination, (ii) computational methods for studying protein structure, (iii) synthetic peptide chemistry, and (iv), computational fragment-based drug design. John works closely with the Evrys Bioresearch team to apply computational chemistry to the discovery of Evrys Bio small molecule sirtuin modulators.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evrys Bio

Evrys Bio’s approach to antiviral therapy is different. Uniquely, Evrys Bio antivirals target special human proteins, known as sirtuins, enhancing their natural ability to fight powerful infections.


Industries

Employees

11-50

Links